menu
    • menu
    [{"orgOrder":0,"company":"Amphix Bio","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"U.S.A","productType":"Peptide","year":"2025","type":"Inapplicable","leadProduct":"AMFX-200","moa":"CD29","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Preclinical","graph3":"Amphix Bio","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amphix Bio \/ Undisclosed","highestDevelopmentStatusID":"4","companyTruncated":"Amphix Bio \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Amphix Bio

    Menu

    Amphix Bio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Amphix Bio

                            U.S.A arrow
                            BIOHK2025
                            Not Confirmed

                            Amphix Bio

                            U.S.A arrow
                            BIOHK2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : AMFX-200

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Study Phase : Preclinical

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Amphix Bio Gets FDA Orphan Drug Status For Spinal Cord Injury Therapy

                            Details : AMFX-200 is a CD29 agonist peptde drug candidate which is currently being evaluated for the treatment of spinal cord injury.

                            Product Name : AMFX-200

                            Product Type : Peptide

                            Upfront Cash : Inapplicable

                            July 16, 2025

                            Lead Product(s) : AMFX-200

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Highest Development Status : Preclinical

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth